European consortium awarded €6.5M to study psychedelic-assisted therapy

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

Related Keywords

Denmark ,Czech Republic ,Bispebjerg ,Hovedstaden ,Uppsala ,Uppsala Lan ,Sweden ,Netherlands ,Groningen ,Stockholm ,Copenhagen ,Køavn ,Portugal ,Sommer Champalimaud ,Carlos Montez Champalimaud ,Robert Schoevers ,National Institute Of Mental Health ,European Psychiatric Association ,European Federation Of Neurological Associations ,Research Europe Alliance ,University Medical Center Groningen ,European Union ,Uppsala University ,Champalimaud Foundation ,Lung Alliance Netherlands ,University Medical Centre Groningen ,Business School ,University Of Stockholm ,University Of Groningen ,University Of Copenhagen ,European Association For Palliative Care ,Carlos Montez ,National Institute ,Mental Health ,Bispebjerg Hospital ,Horizon Europe ,European Association ,Palliative Care ,European Federation ,Neurological Associations ,Norrsken Mind ,Psychedelic Access ,Research ,Amyotrophic Lateral Sclerosis ,Anxiety ,Dancer ,Hronic ,Clinical Trial ,Depression ,Hospital ,Multiple Sclerosis ,Arkinson 39s Disease ,Psychotherapy ,Clerosis ,